Adipokines as targets in musculoskeletal immune and inflammatory diseases-Reference-Cited by-同舟云学术

Adipokines as targets in musculoskeletal immune and inflammatory diseases

Published:2022-11 Issue:11 Volume:27 Page:103352
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

González-Rodríguez María,Ruiz-Fernández Clara,Cordero-Barreal Alfonso,Ait Eldjoudi Djedjiga,Pino Jesus,Farrag Yousof,Gualillo Oreste

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference200 articles.

1. Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases;Recinella;Front Physiol,2020

2. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019;Cieza;Lancet,2020

3. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing’s syndrome;Masuzaki;J Clin Endocrinol Metab,1997

4. Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro;Kolaczynski;Diabetes,1996

5. Stimulation of leptin release by arachidonic acid and prostaglandin E2 in adipose tissue from obese humans;Fain;Metabolism,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration;Pharmacological Research;2024-07

2. The effect of plasma cytokines on the expression of adiponectin and its receptors in the synovial membrane of joints and the infrapatellar fat pad in patients with rheumatoid arthritis and osteoarthritis;Prostaglandins & Other Lipid Mediators;2024-06

3. Special Issue “Adipokines, Myokines, and Physical Exercise in Health and Disease 2.0”;International Journal of Molecular Sciences;2024-01-11

4. Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets;Biomedicines;2023-11-08

5. Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention;Frontiers in Immunology;2023-09-12